Cisplatin-associated nephrotoxicity and pathological events.

@article{Taguchi2005CisplatinassociatedNA,
  title={Cisplatin-associated nephrotoxicity and pathological events.},
  author={Takashi Taguchi and Arifa Nazneen and M. Ruhul Abid and Mohammed S Razzaque},
  journal={Contributions to nephrology},
  year={2005},
  volume={148},
  pages={
          107-21
        }
}
Cisplatin (cis-diamminedichloroplatinum(II)) is an effective chemotherapeutic agent, and is successfully used in the treatment of a wide range of tumors. Despite its effectiveness as an anti-tumor drug, nephrotoxic side effects have significantly restricted its clinical use. Tubular epithelial cell deletion following cisplatin treatment is a major cause of renal injury. Oxidative stress significantly contributes to cisplatin-associated cytotoxicity, and use of antioxidants could counteract such… Expand
An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity
TLDR
This review presents an integrative view of the pathophysiological effects of cisplatin on tubular, vascular, glomerular, and interstitial function and the interplay among these actions. Expand
Chart Review of Predisposing Factors to Cisplatin-Induced Nephrotoxicity in Patients with Cancer
TLDR
The validated criteria for classifying acute kidney injury previously used in studies include the Risk, Injury, Failure, Loss, and End-Stage Kidney Disease (RIFLE) crite Chart Review of Predisposing Factors to CisplatinInduced Nephrotoxicity in Patients with Cancer. Expand
Acute nephrotoxicity of cisplatin: molecular mechanisms.
  • L. Peres, Ademar Dantas da Cunha
  • Medicine
  • Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia
  • 2013
TLDR
The cisplatin nephrotoxicity is a major limiting factors in 20% of patients who have received the drug, triggering injuries in renal tubular epithelial cells, reviewing the main molecular mechanisms that lead to tubular cisPlatin toxicity. Expand
Effect of erythropoietin therapy on the progression of cisplatin induced renal injury in rats.
TLDR
EPO may be one of the futures therapeutic possibilities to overcome the side effects of anti-cancer drugs induced acute renal injury through various mechanisms including down regulation of vascular endothelial growth factor (VEGF), hemeoxygenase-1 (HO-1) and inducible nitric oxide synthase (iNOS) expressions in addition to stimulation of tubular cell regeneration. Expand
Effect of JNK inhibition on cisplatin-induced renal damage.
TLDR
The protective effect of SP600125 on cisplatin-induced renal damage seems to be related to the reduction in the apoptotic cell death and to the restriction of renal inflammation. Expand
Regulation and Pathological Role of p53 in Cisplatin Nephrotoxicity
  • M. Jiang, Z. Dong
  • Medicine
  • Journal of Pharmacology and Experimental Therapeutics
  • 2008
TLDR
Investigation of the signaling pathways upstream and downstream of p53 are being investigated and related to renal cell injury and death may integrate p53 signaling with other nephrotoxic signaling pathways, providing a comprehensive understanding of cisplatin nephrosis and leading to the development of effective renoprotective strategies during cancer therapy. Expand
Mechanisms of Cisplatin Nephrotoxicity
TLDR
Recent advances in understanding of cisplatin nephrotoxicity are summarized and it is discussed how these advances might lead to more effective prevention. Expand
Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research.
  • B. Ali, M. Al Moundhri
  • Chemistry, Medicine
  • Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
  • 2006
TLDR
A review of the studies that have been tested to see whether they could ameliorate or augment the nephrotoxicity of platinum drugs and the possible mechanisms of actions of these agents concludes that combining these agents with cisplatin should be avoided. Expand
Tropisetron attenuates cisplatin-induced nephrotoxicity in mice.
TLDR
Tropisetron treatment markedly ameliorated the experimental cisplatin induced-nephrotoxicity and this effect might be 5-HT3 receptor and α7nAChR independent. Expand
Nephroprotective efficacy of ceftriaxone against cisplatin-induced subchronic renal fibrosis in rats
TLDR
It is concluded that CTX is endowed with antifibrotic properties and could be used as adjuvant therapy to improve CDDP-induced nephrotoxicity and may exhibit a new therapeutic choice for treating renal fibrotic diseases. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 91 REFERENCES
Cisplatin nephrotoxicity.
TLDR
Low single nephron glomerular filtration rates during early cisplatinum-induced acute renal failure is accompanied by reduced renal blood flow and transglomerular hydro static pressure without elevated intratubular hydrostatic pressure, suggesting preglomerular vasoconstriction as an important determinant of renal failure. Expand
Apoptosis induced by cisplatin nephrotoxic injury.
  • A. Lau
  • Biology, Medicine
  • Kidney international
  • 1999
TLDR
Elucidation of the molecular mechanisms of cisplatin nephrotoxicity may lead to the development of a novel therapeutic strategy that targets cancer cell death while simultaneously minimizing renal injury. Expand
Amifostine reduces the incidence of cumulative nephrotoxicity from cisplatin: laboratory and clinical aspects.
TLDR
Amifostine is the only available therapy that can ameliorate the cumulative nephrotoxic effects of cisplatin without reducing antitumor efficacy. Expand
Reduction of cis-platinum induced nephrotoxicity by zinc histidine complex : the possible implication of nitric oxide.
TLDR
The observed inhibition in cisplatin induced renal and hepatic lipid peroxidation by [Zn-Hist] pretreatment, suggests an importance for Zn in stabilisation of membrane integrity probably through the displacement of the redox-active metals that may be responsible for inducing peroxidative damage at target sites. Expand
Efficacy and safety of high-dose cisplatin and cyclophosphamide with glutathione protection in the treatment of bulky advanced epithelial ovarian cancer
TLDR
The results of this study indicate that the use of GSH is a safe new method for high-dose cisplatin administration and well-tolerated and very effective in ovarian cancer patients with bulky disease and warrants further evaluation. Expand
Methylglyoxal Enhances Cisplatin-induced Cytotoxicity by Activating Protein Kinase Cδ*
TLDR
MGO synergistically enhances cisplatin-induced apoptosis through activation of PKCδ and that PKC δ is critical to both cell death and cell survival pathways. Expand
Protection by ebselen against cisplatin-induced nephrotoxicity: Antioxidant system
TLDR
It is suggested that the protection offered by ebselen against cisplatin-induced nephrotoxicity is partly related to the sparing of antioxidant system. Expand
Effect of vitamin C supplementation against cisplatin-induced toxicity and oxidative DNA damage in rats.
TLDR
Investigation of the effects of cisplatin and vitamin C on the renal toxicity and on the oxidative DNA damage in rats demonstrated that depending on the treatment protocol, there were alterations in parameters such as body weight, urinary volume and urinary creatinine, indicating some kidney toxicity. Expand
Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-alpha.
TLDR
Salicylate acts via inhibition of TNF-alpha production to reduce cisplatin nephrotoxicity and may be mediated via stabilization of I kappa B. Expand
Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin.
TLDR
For carboplatin, hydration is important for patients with impaired renal function and for patients receiving high doses of drug, and for ormplatin, renal toxicity appears not be prominent whenHydration is administered in a fashion similar to cisplatin hydration. Expand
...
1
2
3
4
5
...